Indication

Irritable bowel syndrome

Irritable bowel syndrome is a chronic disorder of gut-brain interaction that affects the digestive tract, primarily the large intestine, and occurs predominantly in adults, with a higher prevalence among women. Read more about Irritable bowel syndrome

69 drugs 50 manufacturers

Advertisement

Drugs that treat it

Common Irritable bowel syndrome therapies.

Showing 55–63 of 69 drugs

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
Pfizer Laboratories

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
SLATE RUN PHARM

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
APHENA PHARMA S

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
FOSUN PHARMA US

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
ADVAGEN PHARMA

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
PD-RX PHARM

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
Allen's Cylinder

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
NOVITIUM/ANI PH

DICYCLOMINE HCL

ANTICHOLINERGIC ANTISPASMODICS·IRRITABLE BOWEL SYNDROME
Hikma Pharmaceuticals USA
Filter & compare in the drug finder →Opens the drug finder with Irritable bowel syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Irritable bowel syndrome.

Irritable bowel syndrome is a chronic disorder of gut-brain interaction that affects the digestive tract, primarily the large intestine, and occurs predominantly in adults, with a higher prevalence among women.

It is clinically characterized by recurrent abdominal pain associated with defecation, accompanied by changes in stool frequency, consistency, or both, as well as symptoms such as abdominal distension and bloating.

The underlying pathophysiology involves multifactorial mechanisms, including abnormal gastrointestinal motility, visceral hypersensitivity, altered gut-brain neural signaling, immune dysregulation, and disruptions in the intestinal mucosal barrier and microbiome.

Symptoms typically present in fluctuating, relapsing patterns categorized clinically into subtypes dominated by diarrhea, constipation, or alternating mixed bowel habits.

Personalize your experience

Follow Irritable bowel syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it